Literature DB >> 18166231

GMCSF in the absence of other cytokines sustains human dendritic cell precursors with T cell regulatory activity and capacity to differentiate into functional dendritic cells.

Sriram Chitta1, Laura Santambrogio, Lawrence J Stern.   

Abstract

Dendritic cell precursors, from human peripheral blood, express epitopes reactive with monoclonal antibodies specific for the empty conformation of HLA-DR1. Expression is substantially up-regulated during GMCSF-induced differentiation to immature dendritic cells, but is strongly down-regulated by IL-4. In the conventional protocol for in vitro generation of human dendritic cells from monocyte precursors, both GMCSF and IL-4 are used together, with IL-4 thought to have an effect on preventing macrophage outgrowth but not substantially altering the dendritic cell maturation pathway, whereas conventional protocols for generation of murine dendritic cells use GMCSF alone. We characterized human monocytes cultured in the presence of GMCSF and in the absence of IL-4, and found that the resultant cultures are stable for long periods in vitro, and have T cell stimulatory and immunodulatory activity characteristic of immature dendritic cells. Their response to maturation stimuli is weak in the absence of IL-4 but these cells retain the ability to differentiate into fully functional mature dendritic cells upon IL-4 treatment. We suggest that these cells may provide a useful model to investigate tolerogenic function as a developmental feature of DC and to understand molecular events involved in IL-4 priming for maturation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18166231     DOI: 10.1016/j.imlet.2007.11.013

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  15 in total

1.  Colonic Insult Impairs Lymph Flow, Increases Cellular Content of the Lymph, Alters Local Lymphatic Microenvironment, and Leads to Sustained Inflammation in the Rat Ileum.

Authors:  Walter Cromer; Wei Wang; Scott D Zawieja; Pierre-Yves von der Weid; M Karen Newell-Rogers; David C Zawieja
Journal:  Inflamm Bowel Dis       Date:  2015-07       Impact factor: 5.325

2.  Expression of CD14, IL10, and Tolerogenic Signature in Dendritic Cells Inversely Correlate with Clinical and Immunologic Response to TARP Vaccination in Prostate Cancer Patients.

Authors:  Luciano Castiello; Marianna Sabatino; Jiaqiang Ren; Masaki Terabe; Hanh Khuu; Lauren V Wood; Jay A Berzofsky; David F Stroncek
Journal:  Clin Cancer Res       Date:  2017-01-10       Impact factor: 12.531

Review 3.  Immunotherapy with myeloid cells for tolerance induction.

Authors:  Mercedes Rodriguez-García; Peter Boros; Jonathan S Bromberg; Jordi C Ochando
Journal:  Curr Opin Organ Transplant       Date:  2010-08       Impact factor: 2.640

4.  Activation of the inflammasome and enhanced migration of microparticle-stimulated dendritic cells to the draining lymph node.

Authors:  Ismail M Meraz; Brenda Melendez; Jianhua Gu; Stephen T C Wong; Xuewu Liu; Helen A Andersson; Rita E Serda
Journal:  Mol Pharm       Date:  2012-06-08       Impact factor: 4.939

5.  Lipopolysaccharide-induced expression of TRAIL promotes dendritic cell differentiation.

Authors:  Young S Cho; Sreerupa Challa; Lauren Clancy; Francis K-M Chan
Journal:  Immunology       Date:  2010-04-06       Impact factor: 7.397

6.  15 kDa Granulysin versus GM-CSF for monocytes differentiation: analogies and differences at the transcriptome level.

Authors:  Luciano Castiello; David F Stroncek; Michael W Finn; Ena Wang; Francesco M Marincola; Carol Clayberger; Alan M Krensky; Marianna Sabatino
Journal:  J Transl Med       Date:  2011-04-18       Impact factor: 5.531

7.  Differentiation potential of CD14+ monocytes into myofibroblasts in patients with systemic sclerosis.

Authors:  Nadine Binai; Steven O'Reilly; Bridget Griffiths; Jacob M van Laar; Thomas Hügle
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

8.  Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans.

Authors:  Carmela De Santo; Mariolina Salio; S Hajar Masri; Laurel Yong-Hwa Lee; Tao Dong; Anneliese O Speak; Stefan Porubsky; Sarah Booth; Natacha Veerapen; Gurdyal S Besra; Hermann-Josef Gröne; Frances M Platt; Maria Zambon; Vincenzo Cerundolo
Journal:  J Clin Invest       Date:  2008-11-13       Impact factor: 14.808

9.  Cell therapy using tolerogenic dendritic cells in transplantation.

Authors:  Aurélie Moreau; Emilie Varey; Laurence Bouchet-Delbos; Maria-Cristina Cuturi
Journal:  Transplant Res       Date:  2012-09-28

10.  Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials.

Authors:  Aurélie Moreau; Emilie Varey; Gaëlle Bériou; Marcelo Hill; Laurence Bouchet-Delbos; Mercedes Segovia; Maria-Cristina Cuturi
Journal:  Front Immunol       Date:  2012-08-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.